Equity
Preferred Stock
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 5, 2026
How to read this metric
The presence of preferred stock indicates a specific capital allocation strategy to raise funds without diluting common voting control.
Detailed definition
This represents the par value of issued preferred shares, which hold a higher claim on assets and earnings than common s...
Peer comparison
Used by companies to optimize capital structure; not all companies have preferred stock in their equity mix.
Metric ID:
preferred_stockHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Range$0 – $0
Preferred Stock at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's preferred stock?
- Neurocrine Biosciences (NBIX) reported preferred stock of $0 in Q1 2026.
- What does preferred stock mean?
- The value of shares that have priority over common stock for dividends and assets.